| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 07/12/2011 | CA2432708C Process for the synthesis of a peptide having a trp residue |
| 07/12/2011 | CA2362527C A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer |
| 07/12/2011 | CA2355399C Peptides and peptide analogues designed from hfe protein and their uses in the treatment of iron overload diseases |
| 07/07/2011 | WO2011082289A1 Cyclosporine analogues |
| 07/07/2011 | WO2011080947A1 Composition for improving brain function and method for improving brain function |
| 07/07/2011 | WO2011079817A1 Dendrimer of tuftsin and influenza matrix protein，and use thereof |
| 07/07/2011 | WO2011079621A1 Method for synthesizing and preparing eptifibatide |
| 07/07/2011 | WO2011035330A4 Oxytocin receptor agonists |
| 07/07/2011 | WO2011014707A3 Therapeutic agents for reducing parathyroid hormone levels |
| 07/07/2011 | WO2010057275A8 Cyclic peptides and uses thereof |
| 07/07/2011 | US20110166322 Alpha-conotoxin peptides |
| 07/07/2011 | US20110166320 Somatostatin analogues |
| 07/07/2011 | US20110166084 Controlled release composition and method of producing the same |
| 07/07/2011 | US20110166083 Peptide analogues, particularly for the treatment of chronic pain |
| 07/07/2011 | US20110166080 Deuterated cyclosporine analogs and methods of making the same |
| 07/07/2011 | US20110166075 Method of treating degenerative disorders of the nervous system by administration of fibrinogen fragment |
| 07/07/2011 | US20110166073 Anti-hypertensive agent |
| 07/07/2011 | US20110166072 Polypeptides Selective for avB3 Integrin, Including Pegylated Polypeptides, And Pharmaceutical Uses Thereof |
| 07/07/2011 | US20110166063 Polymer conjugates of therapeutic peptides |
| 07/07/2011 | US20110166043 Biomarker detection-2 |
| 07/07/2011 | US20110165674 NK-1 Receptor Mediated Delivery of Agents to Cells |
| 07/07/2011 | US20110165656 Fungal transcriptional activators useful in methods for producing a polypeptide |
| 07/07/2011 | US20110165647 Nanoparticle conjugates |
| 07/07/2011 | US20110165603 Small molecule fluorescent sensors for detection of post-translationalmodifications and protein interactions in bioassays |
| 07/07/2011 | US20110165225 Modified Drugs for Use in Liposomal Nanoparticles |
| 07/07/2011 | US20110165185 Immunogenic peptides |
| 07/07/2011 | US20110165184 Cdh3 peptide and medicinal agent comprising the same |
| 07/07/2011 | US20110165166 Lsr receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications |
| 07/07/2011 | US20110165165 Mammalian genes; related reagents and methods |
| 07/07/2011 | US20110165148 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 07/07/2011 | US20110165083 Peptides that home to tumor lymphatic vasculature and methods of using same |
| 07/07/2011 | US20110165079 Peptide for transmigration across blood brain barrier and delivery systems comprising the same |
| 07/07/2011 | US20110165075 Integrin targeting agents and in-vivo and in-vitro imaging methods using the same |
| 07/07/2011 | CA2785978A1 Cyclosporine analogues |
| 07/07/2011 | CA2784132A1 Composition for improving brain function and method for improving brain function |
| 07/06/2011 | EP2341077A1 Adenocarcinoma specific antibody SAM-6, and uses thereof |
| 07/06/2011 | EP2341072A2 Method for Generating Activated T-Cells and Antigen-Pulsed Antigen-Presenting Cells |
| 07/06/2011 | EP2341065A2 Inhibitors of serine proteases, particularly HCV NS3-NS4a protease |
| 07/06/2011 | EP2340258A2 Methods for synthesis and uses of inhibitors of ghrelin o-acyltransferase as potential therapeutic agents for obesity and diabetes |
| 07/06/2011 | EP2340048A1 Polymer conjugates of biphalin peptides |
| 07/06/2011 | EP2340045A1 Polymer conjugates of protegrin peptides |
| 07/06/2011 | CN1871022B Peptides and compounds that bind to a receptor |
| 07/06/2011 | CN102119171A CDCA1 epitope peptides and vaccines containing the same |
| 07/06/2011 | CN102119170A MYBL2 epitope peptides and vaccines containing the same |
| 07/06/2011 | CN102119169A IQGAP3 epitope peptides and vaccines containing the same |
| 07/06/2011 | CN102115492A Vascular endothelial growth factor receptor partial polypeptide and application thereof |
| 07/06/2011 | CN101648991B Small peptide C with antibacterial and antitumor functions and applications thereof |
| 07/06/2011 | CN101111258B Emulsified composition for dilution and cancer vaccine composition |
| 07/05/2011 | US7973219 Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants |
| 07/05/2011 | US7972848 Isolation and identification of cross-reactive T cells |
| 07/05/2011 | US7972811 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 07/05/2011 | CA2446971C Use of 3-position cyclosporin derivatives for hair growth |
| 07/05/2011 | CA2390081C Modified viral surface proteins which bind to cells of tumor vasculature |
| 06/30/2011 | WO2011075789A1 Antibodies to non-functional oligomeric p2x7 receptors |
| 06/30/2011 | WO2011014025A3 Derivative of hydroxy-cinnamic acid in which a peptide has been bonded, production method for same, and cosmetic composition comprising same |
| 06/30/2011 | WO2011008992A3 Peptides whose uptake in cells is controllable |
| 06/30/2011 | US20110160432 Myocardial peptide, preparation method and uses thereof |
| 06/30/2011 | US20110160431 Production of peptides containing poly-gly sequences using fmoc chemistry |
| 06/30/2011 | US20110160147 Novel dual targeting antitumoral conjugates |
| 06/30/2011 | US20110160146 Conjungation of Small Molecules to Octaarginine Transporters for Overcoming Multi-Drug Resistance |
| 06/30/2011 | US20110160141 Neurotrophic Peptides |
| 06/30/2011 | US20110160139 Composition for improving brain function and method for improving brain function |
| 06/30/2011 | US20110160120 Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| 06/30/2011 | US20110160119 Anti-inflammatory compounds and uses thereof |
| 06/30/2011 | US20110159532 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 06/30/2011 | US20110159034 Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 06/30/2011 | US20110159027 S. agalactiae antigens i & ii |
| 06/30/2011 | US20110159022 Immunogenic Peptides Derived from the Midkine Protein, as an Anticancer Vaccine |
| 06/30/2011 | US20110159021 Xbp1, cd138, and cs1 peptides |
| 06/30/2011 | US20110158994 Polypeptides specifically binding to vascular endothelial growth factor receptor-2 and methods therefor |
| 06/30/2011 | US20110158981 Methods and Compositions for Inhibiting Binding of IgE to a High Affinity Receptor |
| 06/30/2011 | US20110158956 Treating cancer |
| 06/30/2011 | US20110158941 Crystalline recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof |
| 06/30/2011 | US20110158938 Il-15 binding site for il 15-ralpha and specific il-15 mutants having agonists / antagonists activity |
| 06/30/2011 | CA2785410A1 Tyrosine bioconjugation through aqueous ene-like reactions |
| 06/30/2011 | CA2784345A1 Antibodies to non-functional oligomeric p2x7 receptors |
| 06/30/2011 | CA2782796A1 Compositions and methods for the treatment of angiogenesis-related eye diseases |
| 06/29/2011 | EP2338898A1 Compositions and methods related to profiling a plurality of cell lines based on peptide binding |
| 06/29/2011 | EP2338897A1 Peptides and compounds that bind to a thrombopoietin receptor |
| 06/29/2011 | EP2338522A1 Antitumoural therapies |
| 06/29/2011 | EP2337789A2 Genus-wide chlamydial peptide vaccine antigens |
| 06/29/2011 | EP2337788A1 Method of making biologically active alpha-beta peptides |
| 06/29/2011 | EP1114151B1 G protein-coupled receptor antagonists |
| 06/29/2011 | CN102112487A Process for preparing caspofungin and intermediates thereof |
| 06/29/2011 | CN101440126B Acquisition and use of homing polypeptide with targeting specificity related to tumor and metastases thereof |
| 06/29/2011 | CN101289496B Epitope screening method capable of exciting anti-mycobacterium tuberculosis protective immunological reaction of body and uses |
| 06/28/2011 | US7968097 Identification of Hla-A2-presented T-cell epitopes derived from the oncofoetal antigen-immature laminin receptor protein and uses thereof |
| 06/28/2011 | CA2550264C Method and device for detecting feline immunodeficiency virus |
| 06/28/2011 | CA2380305C Streptogramin derivatives, production thereof and compositions containing the same |
| 06/28/2011 | CA2259944C Melanoma associated peptide analogues and vaccines against melanoma |
| 06/23/2011 | WO2011074578A1 Peptides imparting cell permeability to lipid membrane structure and/or enhancing cell permeability of lipid membrane structure, and lipid membrane structure comprising lipid bound to such peptide as constituent lipid and having cell permeability or showing enhanced cell permeability |
| 06/23/2011 | WO2011074236A1 Tmem22 peptides and vaccines including the same |
| 06/23/2011 | WO2011072991A1 Peptide |
| 06/23/2011 | WO2011072487A1 Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof |
| 06/23/2011 | WO2011072482A1 Nano cancer barrier device(ncbd) to immobilize and inhibit the division of metastic cancer stem cells |
| 06/23/2011 | WO2011036444A4 Heparin cofactor ii fragments with anti-inflammatory and anti-coagulant activity |
| 06/23/2011 | WO2011019839A3 Glycopeptide and lipoglycopeptide antibiotics with improved solubility |
| 06/23/2011 | US20110154522 BH3 Peptides And Method Of Use Thereof |
| 06/23/2011 | US20110152203 Transfection agent |
| 06/23/2011 | US20110152200 Methods and compositions for inhibition of bcl6 repression |